These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9838465)

  • 21. Recurrence of hepatitis B virus cirrhosis and hepatocellular carcinoma: an indication for retransplantation?
    Ringe B; Böker K; Schlitt HJ; Sproviero J; Hundrieser J; Tillmann HL; Chavan A; Flemming P; Galanski M; Pichlmayr R
    Clin Transplant; 1995 Jun; 9(3 Pt 1):190-6. PubMed ID: 7549059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
    Ranki M; Schätzl HM; Zachoval R; Uusi-Oukari M; Lehtovaara P
    Hepatology; 1995 Jun; 21(6):1492-9. PubMed ID: 7768492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus.
    Ju W; Chen M; Guo Z; Wang D; Zhu X; Huang J; He X
    Exp Clin Transplant; 2013 Jun; 11(3):245-9. PubMed ID: 23176583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients.
    Gugenheim J; Crafa F; Fabiani P; Goubaux B; Ouzan D; Mouiel J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1349-50. PubMed ID: 8442140
    [No Abstract]   [Full Text] [Related]  

  • 26. Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B.
    Bzowej N; Han S; Degertekin B; Keeffe EB; Emre S; Brown R; Reddy R; Lok AS;
    Liver Transpl; 2009 Sep; 15(9):1010-20. PubMed ID: 19718627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft hepatitis delta virus reinfection after orthotopic liver transplantation in HDV cirrhosis.
    Reynès M; Zignego L; Samuel D; Fabiani B; Gugenheim J; Tricottet V; Brechot C; Bismuth H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2424-5. PubMed ID: 2652792
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunoprophylaxis for hepatitis B virus reinfection after liver transplantation.
    Jeng LB; Lee WC; Yeh DS; Wang CC; Wang KL; Chen SC; Chen MF; Chien RN; Chiu CT; Lin DY
    Transplant Proc; 1994 Aug; 26(4):2243-4. PubMed ID: 8066736
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experiences with liver transplantation in hepatitis B antigen positive liver cirrhosis].
    Steininger R; Mühlbacher F; Längle F; Gnant M; Sautner T; Götzinger P; Walgram M; Penner E; Radaszkiewicz T
    Wien Klin Wochenschr; 1991; 103(19):573-6. PubMed ID: 1759457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B infection as a major cause of primary liver carcinoma.
    Trichopoulos D; Tzonou A; Zavitsanos X
    Ann Ist Super Sanita; 1987; 24(2):251-6. PubMed ID: 2840010
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatocellular carcinoma in unrelated viral cirrhosis: long-term results after liver transplantation.
    Lauterio A; Di Sandro S; Slim A; Giacomoni A; Mangoni I; Mihaylov P; Pirotta V; Aseni P; De Carlis L
    Transplant Proc; 2010 May; 42(4):1212-5. PubMed ID: 20534264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
    Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
    Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and risk factors of the HBV recurrence after orthotopic liver transplantation: 160 cases follow-up study.
    Xie SB; Zhu JY; Ying Z; Zeng LJ; Chao M; Lu MQ
    Transplantation; 2010 Oct; 90(7):786-90. PubMed ID: 20703179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful living donor liver transplantation using a graft from a hepatitis B surface antigen-positive donor.
    Soejima Y; Shimada M; Taketomi A; Yoshizumi T; Uchiyama H; Ikegami T; Nakamuta M; Maehara Y
    Liver Int; 2007 Nov; 27(9):1282-6. PubMed ID: 17919241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B and hepatocellular carcinoma recurrence after living donor liver transplantation: The role of the Milan criteria.
    Vatansever S; Farajov R; Yılmaz HC; Zeytunlu M; Paköz ZB; Kılıç M
    Turk J Gastroenterol; 2019 Jan; 30(1):75-80. PubMed ID: 30644364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B viral infection: part I. Clinical features.
    Dzik WH; Alter HJ
    Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent infection of humans with hepatitis B virus: mechanisms and consequences.
    Ganem D
    Rev Infect Dis; 1982; 4(5):1026-47. PubMed ID: 6293033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India--an autopsy study.
    Sundaram C; Reddy CR; Ramana GV; Benerjea S; Venkataratnam G; Kumari GS; Reddy BS; Bhaskaran CS
    Indian J Pathol Microbiol; 1990 Oct; 33(4):334-8. PubMed ID: 1966741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Need for hepatocellular carcinoma screening before renal transplantation in HBs +, HBe +, western African.
    Hiesse C; Cantarovich M; Charpentier B; Francais P; Benoit G; Fries D
    Clin Nephrol; 1985 Oct; 24(4):209-11. PubMed ID: 2998662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.